GlassScriptPhysician profile
David Mantilla
NPI 1598252835
$6,521.52
in general payments reported to CMS, 2019-2025
9 companies · $1,202 in 2025
The $1,202 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.90 · 2022: $16.72 · 2023: $296 · 2024: $4,994 · 2025: $1,202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,290 · Travel and Lodging: $2,836 · Education: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,289.53 |
| Travel and Lodging | $2,835.60 |
| Education | $366.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,656.72 | 2022-2025 | Endurant Iis, Valiant Captivia, Heli-Fx Endoanchor System |
| Bard Peripheral Vascular, INC. | $293.63 | 2024 | Lutonix Drug Coated Balloon |
| W. L. Gore & Associates, INC. | $269.69 | 2025 | Gore Excluder Aaa Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Bolton Medical INC | $122.90 | 2024 | Treo Abdominal Stent-Graft System |
| Inari Medical, INC. | $56.46 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $51.59 | 2025 | Jetstream Sc |
| Ethicon US, LLC | $31.62 | 2024-2025 | Surgicel Nu-Knit, Echelon; Endopath |
| Shockwave Medical, INC | $26.01 | 2025 | |
| Currax Pharmaceuticals LLC | $12.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mantilla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.